# Sprott Physical Silver Trust: financial statements, quarterly

PSLV · NYSE · CIK 1494728 · [Financials](/sectors/financials.md)

Pages: [Overview](/companies/pslv.md) · [Financials](/companies/pslv/financials.md) · [Filings](/companies/pslv/filings.md) · [Insiders](/companies/pslv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pslv/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.0](/filings/0001558370-18-002500.md) | [0.0](/filings/0001558370-19-002650.md) | [0.0](/filings/0001558370-20-003399.md) | [0.0](/filings/0001558370-21-003331.md) | [0.0](/filings/0001387131-22-003795.md) | [0.0](/filings/0001387131-23-003845.md) | [0.0](/filings/0001999371-24-003928.md) | [0.0](/filings/0001999371-25-002921.md) | [0.0](/filings/0001999371-26-005829.md) | [0.0](/filings/0001999371-26-005829.md) | [0.2](/filings/0001999371-26-005829.md) |
| Total assets | $bn | not reported | [0.9](/filings/0001558370-18-002500.md) | [1.0](/filings/0001558370-19-002650.md) | [0.9](/filings/0001558370-20-003399.md) | [1.1](/filings/0001558370-21-003331.md) | [2.4](/filings/0001387131-22-003795.md) | [3.6](/filings/0001387131-23-003845.md) | [4.1](/filings/0001999371-24-003928.md) | [4.1](/filings/0001999371-25-002921.md) | [5.2](/filings/0001999371-26-005829.md) | [15.3](/filings/0001999371-26-005829.md) |
| Total liabilities | $bn | not reported | [0.0](/filings/0001558370-18-002500.md) | [0.0](/filings/0001558370-19-002650.md) | [0.0](/filings/0001558370-20-003399.md) | [0.0](/filings/0001558370-21-003331.md) | [0.0](/filings/0001387131-22-003795.md) | [0.0](/filings/0001387131-23-003845.md) | [0.0](/filings/0001999371-24-003928.md) | [0.0](/filings/0001999371-25-002921.md) | [0.0](/filings/0001999371-26-005829.md) | [0.2](/filings/0001999371-26-005829.md) |
| Shareholders' equity | $bn | [0.7](/filings/0001558370-18-002500.md) | [0.9](/filings/0001558370-19-002650.md) | [1.0](/filings/0001558370-20-003399.md) | [0.9](/filings/0001558370-21-003331.md) | [1.1](/filings/0001387131-22-003795.md) | [2.4](/filings/0001387131-23-003845.md) | [3.6](/filings/0001999371-24-003928.md) | [4.1](/filings/0001999371-25-002921.md) | [4.1](/filings/0001999371-26-005829.md) | [5.2](/filings/0001999371-26-005829.md) | [15.1](/filings/0001999371-26-005829.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 614,415,855 at 2025-12-31, from the cover of the [40-F filed 2026-03-16](/filings/0001999371-26-005829.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.